| Title : Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study - Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447 |
| Author(s) : Rizvi SM , Shakil S , Biswas D , Shaikh S , Bagga P , Kamal MA |
| Ref : CNS Neurol Disord Drug Targets , 13 :447 , 2014 |
| Abstract : Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447 |
| ESTHER : Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447 |
| PubMedSearch : Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447 |
| PubMedID: 24059302 |
Rizvi SM, Shakil S, Biswas D, Shaikh S, Bagga P, Kamal MA (2014)
Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study
CNS Neurol Disord Drug Targets
13 :447
Rizvi SM, Shakil S, Biswas D, Shaikh S, Bagga P, Kamal MA (2014)
CNS Neurol Disord Drug Targets
13 :447